Virachith Siriphone, Phakhounthong Khanxayaphone, Khounvisith Vilaysone, Mayxay Mayfong, Kounnavong Sengchanh, Sayasone Somphou, Hübschen Judith M, Black Antony P
LaoLuxLab/Vaccine Preventable Diseases Laboratory, Institut Pasteur du Laos, Samsenthai Rd, P.O. Box 3560, Ban Kao-gnot, Vientiane, 01000, Lao People's Democratic Republic, 856 21 285 321.
Lao Tropical and Public Health Institute, Ministry of Health, Vientiane, Lao People's Democratic Republic.
JMIR Public Health Surveill. 2024 Dec 17;10:e65093. doi: 10.2196/65093.
Despite the high prevalence of chronic hepatitis B virus (HBV) infection in adults in Lao People's Democratic Republic (Lao PDR), Lao health care workers (HCWs) have previously been shown to have low levels of protection against infection. Furthermore, the prevalence of hepatitis D virus (HDV), which increases disease severity in individuals infected with HBV, is not known in Lao PDR.
This study aimed to estimate the exposure and seroprotection against HBV, as well as exposure to HDV, in Lao HCWs from 5 provinces.
In 2020, a total of 666 HCWs aged 20 to 65 years from 5 provinces of Lao PDR were recruited, and their sera were tested by enzyme-linked immunosorbent assay to determine their HBV and HDV coinfection status.
HBV exposure, as indicated by the presence of anti-hepatitis B core antibodies, was 40.1% (267/666) overall and significantly higher for HCWs from Oudomxay province (21/31, 67.7%; adjusted odds ratio 3.69, 95% CI 1.68-8.12; P=.001). The prevalence of hepatitis B surface antigen was 5.4% (36/666) overall and increased with age, from 3.6% (9/248) in those aged ≤30 years to 6.8% (8/118) in those aged ≥50 years. Only 28.7% (191/666) of participants had serological indication of immunization. We could find no evidence for HDV exposure in this study.
The study found intermediate hepatitis B surface antigen prevalence among HCWs in Lao PDR, with no evidence of HDV coinfection. Notably, a significant proportion of HCWs remains susceptible to HBV, indicating a substantial gap in seroprotection against the disease.
尽管在老挝人民民主共和国(老挝)成年人中慢性乙型肝炎病毒(HBV)感染率很高,但此前研究表明老挝医护人员对感染的防护水平较低。此外,丁型肝炎病毒(HDV)会增加HBV感染者的疾病严重程度,老挝的HDV感染率尚不清楚。
本研究旨在评估老挝5个省份医护人员HBV暴露及血清保护情况,以及HDV暴露情况。
2020年,招募了老挝5个省份共666名年龄在20至65岁的医护人员,采用酶联免疫吸附试验检测其血清,以确定HBV和HDV合并感染状况。
抗乙型肝炎核心抗体阳性表明总体HBV暴露率为40.1%(267/666),乌多姆赛省医护人员的暴露率显著更高(21/31,67.7%;调整优势比3.69,95%置信区间1.68 - 8.12;P = 0.001)。乙型肝炎表面抗原总体流行率为5.4%(36/666),且随年龄增长而升高,≤30岁者为3.6%(9/248),≥50岁者为6.8%(8/118)。只有28.7%(191/666)的参与者有免疫血清学证据。本研究未发现HDV暴露证据。
该研究发现老挝医护人员中乙型肝炎表面抗原流行率处于中等水平,未发现HDV合并感染证据。值得注意的是,相当一部分医护人员仍易感染HBV,表明在针对该疾病的血清保护方面存在巨大差距。